Nova: Welcome back to The Strategy Session. Today, we are diving deep into a book that fundamentally changed how I view corporate planning: Richard Rumelt’s "Good Strategy/Bad Strategy."

Nova: : I’m ready for this, Nova. I feel like I’ve sat through a hundred strategy sessions that ended with a poster board full of buzzwords and zero actual direction. What makes Rumelt’s take different?

Nova: That’s the million-dollar question, and Rumelt’s answer is brutally simple: Most of what passes for strategy is actually just goal-setting, wishful thinking, or pure corporate fluff. He argues that true strategy is rare, and he gives us the toolkit to spot the good from the bad.

Nova: : So, this isn't about mission statements or vision boards? Because I’ve seen those things plastered everywhere, promising revolutionary change, yet the company just keeps doing the same thing, only louder.

Nova: Exactly. Rumelt says if you can’t point to a clear, focused path that addresses a genuine obstacle, you don't have a strategy. You have a desire. He calls the bad stuff the "four hallmarks of bad strategy," and we’ll get to those villains shortly. But first, we have to understand what we are aiming for.

Nova: : Lay it on us. What does a genuinely good strategy look like according to this legend?

Nova: It looks like a three-part structure he calls the Kernel. It’s elegant, and once you see it, you can’t unsee it. It’s the foundation of everything that follows.

Nova: The Kernel starts with the Diagnosis. This is the most crucial, and often the most painful, step. A good diagnosis clearly defines the nature of the challenge or the obstacle you face. It’s not just saying, “We need more market share.” It’s saying, “Our market share is declining because Competitor X has locked up the distribution channels in the Northeast, and our legacy product line is too expensive to compete on price.”

Nova: : That’s a huge difference. It moves from a vague problem to a specific, actionable constraint. So, the Diagnosis is the 'What is the real problem?' part?

Nova: Precisely. And it requires brutal honesty. Rumelt notes that many leaders skip this because it forces them to admit something is fundamentally wrong or that their current approach isn't working. It’s easier to just declare a goal.

Nova: : Okay, so once we know the problem—the Diagnosis—what’s step two? The Guiding Policy?

Nova: The Guiding Policy is the overall approach you choose to overcome the obstacles identified in the Diagnosis. It’s the strategic thrust. If the diagnosis is that distribution is locked up, the guiding policy might be: “We will bypass traditional distribution by building a direct-to-consumer digital channel focused exclusively on high-margin, custom-configured units.”

Nova: : That sounds like a real decision. It rules out a lot of other things you could be doing, like trying to fight Competitor X head-on in their established territory.

Nova: That’s the beauty of it! A guiding policy is a commitment to a particular path. It sets the boundaries for action. It’s the “how we will win” statement, but framed as a high-level approach, not a list of tasks.

Nova: : And finally, the third element of the Kernel: Coherent Actions. This is where the rubber meets the road, right?

Nova: Absolutely. Coherent Actions are the specific, coordinated steps that implement the Guiding Policy. They must reinforce each other. If your Guiding Policy is to build a direct-to-consumer channel, your actions must include hiring digital marketing experts, redesigning the website for configuration, and setting up a new fulfillment logistics chain. If you hire a digital team but keep using the old, slow fulfillment system, the actions are coherent, and the strategy collapses.

Nova: : So, the Kernel is a chain: Diagnosis identifies the critical link, Guiding Policy dictates how to break that chain, and Coherent Actions are the specific tools used to break it. If any link is weak, the whole thing snaps.

Nova: You nailed it. It’s a system. And the moment you see a plan that’s just a list of good ideas—like “Improve customer service,” “Innovate faster,” and “Increase social media presence”—you know you’re looking at bad strategy because it lacks that binding coherence around a central challenge.

Nova: Let’s pivot to the villains. Rumelt identifies four major hallmarks of bad strategy. The first two are often intertwined: Fluff and Mistaking Goals for Strategy. Let’s start with Fluff.

Nova: : Fluff. I know this language well. It’s the corporate doublespeak, right? Words that sound important but mean nothing specific.

Nova: Exactly. Rumelt describes it as using “Sunday words”—words that sound grand and important but mask an absence of real thinking. Think phrases like “synergistic optimization of core competencies” or “leveraging disruptive innovation across all verticals.” It’s designed to impress stakeholders without committing the organization to any difficult course of action.

Nova: : It’s a shield. If the strategy fails, you can always point back to the impressive language and say, “Well, we followed the plan!”

Nova: Precisely. It creates the illusion of high-level thinking. Now, the second hallmark is arguably more dangerous: Confusing Goals with Strategy. A goal is a desired end state, like “Become the market leader by 2030.” That's a goal. It’s not a strategy.

Nova: : Right. Because how are you going to get there? If I say my goal is to run a marathon, that’s not a strategy. The strategy involves the training plan, the diet changes, the injury prevention—that’s the Guiding Policy and Coherent Actions.

Nova: Perfect analogy. Rumelt stresses that setting goals without a supporting strategy is a recipe for disaster because it encourages everyone to pursue their own pet projects that lead to the goal, but they won't be coordinated. It leads to resource fragmentation.

Nova: : So, if a strategy document is just a list of ambitious targets—like 20% revenue growth, 15% margin improvement, 10% market share gain—that’s a massive red flag?

Nova: It’s a flashing neon sign pointing to bad strategy. Those are outcomes, not the mechanism for achieving them. A good strategy explains you will overcome the competitive forces preventing you from hitting those numbers.

Nova: : What are the other two hallmarks? I’m guessing they relate to the Diagnosis?

Nova: They do. The third is the Failure to Face the Challenge. This is where the Diagnosis step of the Kernel is completely ignored or glossed over. The organization refuses to acknowledge the true, hard problem staring them in the face.

Nova: : Like a doctor telling a patient they just need to “be happier” instead of diagnosing the actual illness.

Nova: A perfect parallel. And the fourth hallmark is the flip side of the Kernel’s coherence: Lack of Coherence. This means the proposed actions don't actually fit together. They might be individually good ideas, but they pull the organization in different directions, canceling each other out. It’s a dog’s dinner of strategic objectives, as Rumelt puts it.

Nova: This brings us neatly to Rumelt’s concept of the Crux, which is really the heart of the Diagnosis. He argues that strategy is fundamentally about focus, and focus requires making hard choices about what you do.

Nova: : That’s a tough sell in most boardrooms. Everyone wants to be everything to everyone. How does the Crux help leaders overcome that?

Nova: The Crux is the single most important challenge that, if overcome, will unlock success. It’s the leverage point. If you can identify the Crux—say, it’s a regulatory hurdle, or a specific technological gap, or a competitor’s unique cost advantage—then your Guiding Policy becomes laser-focused on dismantling that one thing.

Nova: : So, if a company’s Crux is that their manufacturing process is 30% more expensive than the nearest competitor, the Guiding Policy can’t be “Improve efficiency everywhere.” It has to be something like, “Re-engineer the top three cost drivers in the assembly line through automation investment over 18 months.”

Nova: Exactly! That Guiding Policy immediately tells the R&D team where to focus their budget, tells the procurement team which suppliers to pressure, and tells the sales team not to promise deep discounts until the 18 months are up. It creates strategic discipline.

Nova: : And that discipline is what prevents the resource fragmentation we talked about earlier—the bad strategy spreading resources thin across ten mediocre initiatives.

Nova: Rumelt emphasizes that good strategy concentrates power. It identifies the asymmetry—the place where you can gain an advantage—and pours resources there. Bad strategy tries to fight on every front simultaneously, which means you are weak everywhere.

Nova: : It sounds like good strategy is inherently about saying 'No' a lot. Saying 'No' to the exciting side project, saying 'No' to the easy market segment, because they don't address the Crux.

Nova: That’s the essence of it. It’s counterintuitive because we associate strategy with growth and expansion. But Rumelt shows that true strategic power comes from narrowing the field of play. You don't win by being slightly better at everything; you win by being overwhelmingly superior at the one thing that matters most to your success right now.

Nova: We’ve established that the Diagnosis is step one, and it’s the hardest. Why is it so difficult for established organizations to perform an honest diagnosis?

Nova: : I think it’s ego, Nova. If you’re a successful CEO, admitting that the core business model is flawed, or that the market has fundamentally shifted away from your strength, feels like admitting failure.

Nova: It’s organizational inertia mixed with personal risk. Rumelt points out that leaders often mistake the of decline for the. They see falling profits and prescribe cost-cutting across the board—a classic example of a weak diagnosis leading to incoherent, painful actions.

Nova: : So, instead of asking, “Why are profits falling?” they jump to, “How do we stop profits from falling?” The second question is tactical, not strategic.

Nova: Precisely. The strategic question forces you to look outward at the competitive landscape and inward at your own capabilities. Rumelt suggests that often, the challenge isn't an external threat, but an internal one—a set of outdated assumptions or a structure that no longer fits the market reality. Overcoming that internal resistance to change is the real test of leadership.

Nova: : Are there any examples where a company successfully navigated this painful honesty?

Nova: While Rumelt often uses historical examples, the principle applies to modern turnarounds. Think of companies that had to completely abandon a profitable but dying legacy business to invest heavily in a new, uncertain one. That required a Diagnosis that stated: “Our legacy business is a cash cow, but it’s a strategic anchor that prevents us from building the future.” That’s a tough diagnosis to deliver to shareholders who love the dividends.

Nova: : It requires a leader willing to take short-term pain for long-term strategic gain, which is the opposite of what quarterly reporting often rewards.

Nova: It is. And this is where the Guiding Policy comes in again. If the Diagnosis is hard, the Guiding Policy must be bold enough to address it, and the Coherent Actions must be disciplined enough to stick to it, even when the market throws curveballs. The entire Kernel must be robust enough to withstand the political and emotional fallout of admitting the truth.

Nova: We’ve covered a lot of ground today, moving from the abstract concept of strategy to the concrete structure of the Kernel. If listeners take away just one thing from Rumelt’s work, what should it be?

Nova: : It has to be the Kernel itself: Diagnosis, Guiding Policy, Coherent Actions. It’s a simple framework, but it’s incredibly powerful for testing any plan presented to you. If it doesn't have those three linked parts, it’s not strategy; it’s just noise.

Nova: I agree. And I’d add the corollary: Be ruthless in spotting the bad strategy hallmarks. If you see fluff, if you see goals masquerading as strategy, or if the plan avoids naming the real problem—the Crux—then you have permission to dismiss it immediately.

Nova: : It reframes strategy from being about ambition to being about leverage. It’s not about wanting more; it’s about focusing your limited energy on the one place where you can create a disproportionate advantage.

Nova: Exactly. Strategy isn't about being good at everything; it’s about being strategically positioned to win where it counts. It’s about making hard choices and then aligning every resource to execute those choices consistently. It’s about action, not aspiration.

Nova: : So, the next time someone asks for a strategy, we ask them: What is the challenge, what is our approach to that challenge, and what are the three things we are not doing this year?

Nova: That’s the path to real strategic clarity. Richard Rumelt gives us the language to demand substance over style. It’s a challenging read because it forces accountability, but it’s essential reading for anyone leading or participating in an organization.

Nova: : Fantastic breakdown, Nova. I feel equipped to dismantle some fluff this week.

Nova: Excellent. Keep testing those plans against the Kernel. This is Aibrary. Congratulations on your growth!